Intriguingly, studies have reported that psoriasis is an independent risk-factor for T2D and insulin resistance, separate from underlying obesity, with the severity of psoriasis correlating with increased likelihood of developing T2D and the requirement of insulin therapy [5,8]. Here, INS is linked to psoriasis.